Skip to content
healthcare.dev

Temozolomide

NDC 73043-013, Temozolomide, capsule, from Devatis, Inc..

Product NDC
73043-013
Status
Listed
Labeler
Devatis, Inc.
Dosage form
CAPSULE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA207658
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/73043-013 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TEMOZOLOMIDE100 mg/1

Pharmacologic classes

Alkylating Activity [MoA]; Alkylating Drug [EPC]

Package NDCNDC-11Package
73043-013-05730430013055 CAPSULE in 1 BOTTLE (73043-013-05)
73043-013-147304300131414 CAPSULE in 1 BOTTLE (73043-013-14)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/6b263fe0-5f06-4889-bf14-4aa185470810
  • NADAC price for package 73043001305

    GET /v1/drugs/nadac/73043001305
  • NADAC price for package 73043001314

    GET /v1/drugs/nadac/73043001314

Use it

Look up 73043-013 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/73043-013 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 73043-013. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.